NL169314B - METHOD FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH SOURCE CHODILATOR ACTIVITY OBTAINED FROM MEDICINAL PRODUCT OBTAINED BY THIS METHOD AND METHOD FOR PREPARING MEDICINAL COMPOUNDS FOR USE THEREOF - Google Patents

METHOD FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH SOURCE CHODILATOR ACTIVITY OBTAINED FROM MEDICINAL PRODUCT OBTAINED BY THIS METHOD AND METHOD FOR PREPARING MEDICINAL COMPOUNDS FOR USE THEREOF

Info

Publication number
NL169314B
NL169314B NL7007303A NL7007303A NL169314B NL 169314 B NL169314 B NL 169314B NL 7007303 A NL7007303 A NL 7007303A NL 7007303 A NL7007303 A NL 7007303A NL 169314 B NL169314 B NL 169314B
Authority
NL
Netherlands
Prior art keywords
medicinal
medicinal product
chodilator
preparation
source
Prior art date
Application number
NL7007303A
Other languages
Dutch (nl)
Other versions
NL169314C (en
NL7007303A (en
Inventor
G H Sankey
K D E Whiting
Original Assignee
Minnesota 3M Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota 3M Lab Ltd filed Critical Minnesota 3M Lab Ltd
Publication of NL7007303A publication Critical patent/NL7007303A/xx
Publication of NL169314B publication Critical patent/NL169314B/en
Application granted granted Critical
Publication of NL169314C publication Critical patent/NL169314C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/02—Preparation by ring-closure or hydrogenation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
NLAANVRAGE7007303,A 1969-05-20 1970-05-20 METHOD FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH SOURCE CHODILATOR ACTIVITY OBTAINED FROM MEDICINAL PRODUCT OBTAINED BY THIS METHOD AND METHOD FOR PREPARING MEDICINAL COMPOUNDS FOR USE THEREOF NL169314C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2563469 1969-05-20

Publications (3)

Publication Number Publication Date
NL7007303A NL7007303A (en) 1970-11-24
NL169314B true NL169314B (en) 1982-02-01
NL169314C NL169314C (en) 1982-07-01

Family

ID=10230843

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7007303,A NL169314C (en) 1969-05-20 1970-05-20 METHOD FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH SOURCE CHODILATOR ACTIVITY OBTAINED FROM MEDICINAL PRODUCT OBTAINED BY THIS METHOD AND METHOD FOR PREPARING MEDICINAL COMPOUNDS FOR USE THEREOF

Country Status (12)

Country Link
JP (1) JPS4920787B1 (en)
BE (1) BE750590A (en)
CH (1) CH541557A (en)
DE (1) DE2024049C3 (en)
DK (1) DK124027B (en)
FR (1) FR2051549B1 (en)
GB (1) GB1316424A (en)
IL (1) IL34537A (en)
NL (1) NL169314C (en)
NO (1) NO133448C (en)
SE (1) SE374366B (en)
ZA (1) ZA703208B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA960676A (en) * 1970-05-21 1975-01-07 Smith Kline And French Canada Ltd. 3-sulfonamido-4-hydroxyphenyl-2-piperidinylcarbinols
US5169096A (en) * 1985-07-02 1992-12-08 Merrell Dow Pharmaceuticals Inc. N-aralkyl-piperidine-methanol derivatives
WO1991018602A1 (en) * 1990-06-01 1991-12-12 Merrell Dow Pharmaceuticals Inc. (+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL
US6004980A (en) * 1990-06-01 1999-12-21 Merrell Pharmaceuticals, Inc. (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
US6028083A (en) * 1997-07-25 2000-02-22 Hoechst Marion Roussel, Inc. Esters of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE569836A (en) *

Also Published As

Publication number Publication date
FR2051549B1 (en) 1974-08-30
NO133448B (en) 1976-01-26
ZA703208B (en) 1971-01-27
SE374366B (en) 1975-03-03
NL169314C (en) 1982-07-01
DK124027B (en) 1972-09-04
GB1316424A (en) 1973-05-09
CH541557A (en) 1973-09-15
DE2024049C3 (en) 1978-07-20
BE750590A (en) 1970-11-19
IL34537A0 (en) 1970-07-19
NO133448C (en) 1976-05-05
DE2024049B2 (en) 1977-11-24
IL34537A (en) 1973-03-30
DE2024049A1 (en) 1970-12-17
JPS4920787B1 (en) 1974-05-27
FR2051549A1 (en) 1971-04-09
NL7007303A (en) 1970-11-24

Similar Documents

Publication Publication Date Title
NL7503367A (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH NEURO-PSYCHOTROPIC ACTION.
NL182200C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT FOR THE TREATMENT OF CANCER, ON THE BASIS OF A PLATINACOOERD DERIVATION COMPOUND AND METHOD FOR PREPARING THE ACTIVE COMPOUND
NL156922B (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION CONTAINING A CORONARY ACTIVITY, FORMED PHARMACEUTICAL PREPARATION, OBTAINED BY APPLICATION OF THIS PROCEDURE AND PROCEDURE FOR PREPARING CORONAR ACTION COMPOUNDS USED FOR SUITABLE PROCEDURES.
NL7311307A (en) PROCESS FOR THE PREPARATION OF A SWEETENANT.
NL178965C (en) METHOD FOR THE PREPARATION OF MEDICINAL PRODUCTS WITH BETA-ADRENOLYTIC ACTION, FORMED MEDICINAL PRODUCTS CONTAINING THEM AND METHOD FOR PREPARING COMPOUNDS WITH THIS ACTION
NL7415577A (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH CENTRAL-DEPRESSIVE, ANESTHETIC -NARCOTIC ACTION.
NL147016B (en) PROCESS FOR THE PREPARATION OF A HERBICIDE PREPARATION.
NL7411312A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION.
NL167960C (en) PROCESS FOR THE PREPARATION OF NEW ALFA, ALFA-DIG SUBSTITUTED N-BENZYLIMIDAZOLES AND PHARMACEUTICAL PREPARATIONS CONTAINING AT LEAST ONE OF THESE COMPOUNDS
NL176829C (en) PROCESS FOR THE PREPARATION OF A HERBICIDE PREPARATION.
NL7504216A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION.
NL161444C (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANTI-ARRHYTMIC ACTION, FORMED MEDICINAL PRODUCT WITH SUCH ACTION AND PROCESS FOR THE PREPARATION OF A UREA DERIVATIVE.
NL179109C (en) METHOD FOR THE PREPARATION OR MANUFACTURE OF A MEDICINAL PRODUCT CONTAINING A SOBREROL.
NL169314C (en) METHOD FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH SOURCE CHODILATOR ACTIVITY OBTAINED FROM MEDICINAL PRODUCT OBTAINED BY THIS METHOD AND METHOD FOR PREPARING MEDICINAL COMPOUNDS FOR USE THEREOF
NL7502795A (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT HAVING VESSEL-STRENGTHENING, CAPILLAR-SEALING AND / OR ANTIARITHMIC ACTION.
NL149777B (en) PROCESS FOR THE PREPARATION OF A FRAGRANCE MIXTURE AND PROCESS FOR THE PREPARATION OF SUITABLE COMPOUNDS.
NL7413323A (en) PROCESS FOR THE PREPARATION OF A VETERINARY PREPARATION.
NL7506872A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION.
NL7604502A (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANTI-IFLAMMATORE ACTION, A MEDICINAL PRODUCT WITH SUCH ACTION AND A PROCESS FOR PREPARING THE ACTIVE COMPOUNDS.
NL183561C (en) PROCESS FOR THE PREPARATION OF A HERBICIDE PREPARATION.
NL7601418A (en) METHOD FOR THE PREPARATION OF MEDICINAL PRODUCTS WITH STOMACH-CURING ACTION, SUCH MEDICINAL PRODUCT AND METHOD FOR PREPARING THE ACTIVE COMPOUNDS.
NL7408875A (en) PROCESS FOR THE PREPARATION OF ALKALIPOLYPHOSPHATE COMPLEXES WITH ANTIBIOTIC ACTION, PROCEDURE FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH SUCH ACTION AND SUCH MEDICINAL PRODUCT.
NL7501574A (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANTI-ULCUS ACTIVITY, SUCH MEDICINAL PRODUCT AND A PROCESS FOR THE PREPARATION OF THE MEDICINAL COMPOUNDS.
NL150780B (en) PROCESS FOR THE PREPARATION OF AMPHETAMINE DERIVATIVES WITH ANOREXIGENIC ACTION, PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANOREXIGENIC ACTION AND FORMED MEDICINAL PRODUCT.
NL7514062A (en) PROCESS FOR THE PREPARATION OF HALOGENATED BENZOGUANAMINS, PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANTI-ULCUS ACTION AND SUCH MEDICINAL PRODUCT.

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee